Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2004
03/03/2004CN1479611A Pharmaceutical paste comprising acid-labile activeingredient
03/03/2004CN1479610A Drondearone pharmaceutical composition for external gastrointestinal-tract administration
03/03/2004CN1479609A Oral delivery of peptide
03/03/2004CN1479579A Encased food product with contrasting components
03/03/2004CN1478552A Carrier used for carrying radiation substance and its use method
03/03/2004CN1478485A Liposome ointment containing heparin kind medicine and its preparation method
03/03/2004CN1478482A Slow release (controlled releuse) preparation of doufuguosu
03/03/2004CN1478470A Nagelinai clathrate compound
03/03/2004CN1478467A Rapid disintegrate tablet in oral and its preparation method
03/03/2004CN1478465A Biphenyl diester liquid medicinal composition containing fat
03/03/2004CN1140297C Stabilized pharmaceutical compositions and stabilizing solvent
03/03/2004CN1140296C Magnetic medicine-carried conveying material and preparation method thereof
03/03/2004CN1140268C Rapamycin formulations for oral administration
03/03/2004CN1140266C Use of mixture of diol and alpha-hydrox acid for treatment of hyperkeratotic skin diseases
03/03/2004CN1140265C Plasticizer and adhesive plaster containing plasticizer
03/03/2004CN1140262C Prepn. of nano hdyroxycamptothecine-dextran grain
03/03/2004CN1140261C Use of compositions comprising stabilized biologically effective compounds
03/03/2004CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us
03/02/2004US6699978 Linker nucleoside, and production and use of the same
03/02/2004US6699885 Substituted benzimidazole dosage forms and methods of using same
03/02/2004US6699849 Bioavailability
03/02/2004US6699847 Antiparasitic formulation
03/02/2004US6699845 Excipient
03/02/2004US6699843 Method for treatment of tumors using nucleic acid ligands to PDGF
03/02/2004US6699841 Method of preparing physiologically acceptable aqueous solutions, and solutions thus obtained
03/02/2004US6699840 Controlled- or delayed-release forms of topiramate
03/02/2004US6699833 Pharmaceutical formulations for sustained drug delivery
03/02/2004US6699701 Method and device for sanitation using bacteriophages
03/02/2004US6699512 Hypericum perforatum l. oleoresin, procedure for obtaining it and uses of it
03/02/2004US6699507 Metal of palladium, platinum, rhodium or molybdenum made by reducing metal compound with specified reducing agent
03/02/2004US6699505 Wherein biological activity of bioactive agent/complexing agent complex is higher than activity of uncomplexed bioactive agent
03/02/2004US6699504 Drug delivery
03/02/2004US6699503 Hydrogel-forming sustained-release preparation
03/02/2004US6699500 Sustained-release preparation capable of releasing a physiologically active substance
03/02/2004US6699498 Transdermal therapeutic systems having improved stability and their production
03/02/2004US6699497 Permeation enhancer
03/02/2004US6699494 Side effect reduction
03/02/2004US6699493 Performing the transplant, and implanting in the eye a biodegradable drug delivery system comprising an immunosuppressant and a biodegradable polymer
03/02/2004US6699492 Quinolone carboxylic acid compositions and related methods of treatment
03/02/2004US6699483 Cancer treatments
03/02/2004US6699474 Forming hapten conjugate, purification and sterile filtration, administration
03/02/2004US6699471 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders
03/02/2004US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration
03/02/2004US6699315 A hardenable propylene glycol alginate (pga) film-former and a surfactant in an aqueous solution of low viscosity; prompt release for drug and veterinary solid dosage forms, candy, seeds, animal feed, fertilizers, pesticides and foods
03/02/2004US6698162 Methods of producing a terminally sterilized topical patch preparation
03/02/2004CA2198247C Ionene polymers containing biologically-active anions
03/02/2004CA2105836C Bioerodible contraceptive suppository
02/2004
02/26/2004WO2004016801A2 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
02/26/2004WO2004016799A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
02/26/2004WO2004016762A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
02/26/2004WO2004016736A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
02/26/2004WO2004016734A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
02/26/2004WO2004016733A2 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
02/26/2004WO2004016551A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
02/26/2004WO2004016289A1 Topical anhydrous and ethanol-free ascomycin compositions
02/26/2004WO2004016251A1 Sustained release pharmaceutical composition of a cephalosporin antibiotic
02/26/2004WO2004016244A2 Pharmaceutical compositions for buccal delivery of pain relief medications
02/26/2004WO2004016243A2 Methods of administering and enhancing absorption of pharmaceutical agents
02/26/2004WO2004016241A1 Antigenic compositions
02/26/2004WO2004016225A2 Compositions and methods for the diagnosis and treatment of tumor
02/26/2004WO2004016214A2 Methods and compositions for treatment of macular and retinal disease
02/26/2004WO2004016148A2 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
02/26/2004WO2004003188A3 Stabilization of granules
02/26/2004WO2004002423A3 Cartilage enhancing food supplements with sucralose and methods of preparing the same
02/26/2004WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles
02/26/2004WO2004000034A3 Anthelmintic oral homogeneous veterinary pastes
02/26/2004WO2003103624B1 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous
02/26/2004WO2003099337A3 Inclusion complexes of rosiglitazone
02/26/2004WO2003098991A3 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
02/26/2004WO2003096991A3 Amelioration of the development of cataracts and other opthalmic diseases
02/26/2004WO2003096973A3 A direct cellular energy delivery system
02/26/2004WO2003091387A9 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
02/26/2004WO2003090712A3 Compositions for treating hyperemia
02/26/2004WO2003090684A3 Polymer compositions containing a macrocyclic triene compound
02/26/2004WO2003087327A3 Preservation of bioactive materials by freeze dried foam
02/26/2004WO2003086491A3 Tissue defect dressings comprising a keratin network
02/26/2004WO2003086296A3 Treatment for type 1 diabetes before and after expression of predisposition markers.
02/26/2004WO2003082209A3 Cochleates made with purified soy phosphatidylserine
02/26/2004WO2003068805A3 Formulation strategies in stabilizing peptides in organic solvents and in dried states
02/26/2004WO2003062401A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
02/26/2004WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains
02/26/2004WO2003055528A3 Amphiphilic compounds for pharmaceutical or cosmetic use
02/26/2004WO2003053403A3 Pharmaceutical suspension for oral administration
02/26/2004WO2003049684A3 Pseudo-antibody constructs
02/26/2004WO2003043586A9 Compositions for sustained action product delivery
02/26/2004WO2003035011A3 Multidrug multiligand conjugates for targeted drug delivery
02/26/2004WO2003034991A3 Taste masking spill-resistant formulation
02/26/2004WO2003032990A3 Polymer conjugates of opioid antagonists
02/26/2004WO2003032915A3 Viral inhibition by n-docosanol
02/26/2004WO2003026614A9 Dosage form containing a confectionery composition
02/26/2004WO2003015708A3 Composition and method for treating hiv infection
02/26/2004WO2003007733A8 Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid
02/26/2004WO2002098501A3 Method and apparatus for treating tumors using low strength electric fields
02/26/2004WO2002095005A3 Therapeutic dna vaccination
02/26/2004WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
02/26/2004WO2002083058A3 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
02/26/2004WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them
02/26/2004WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
02/26/2004WO2002055067A3 Fumaric acid derivatives as nf-kappab inhibitors
02/26/2004WO2002041910A8 Methods and compositions for the treatment of diseases of the eye